Glycogenotic hepatocellular carcinoma with glycogen-ground-glass hepatocytes: A heuristically highly relevant phenotype

World Journal of Gastroenterology

Volumn 18, Issue 46, 2012, Pages 6701-6708

  Bannasch, Peter ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Acquired focal hepatic glycogenosis; Early metabolic aberrations; Hepatic neoplasia; Hepatic preneoplasia; Inborn hepatic glycogenosis; Progression linked metabolic switch

Indexed keywords

4 DIMETHYLAMINO 3' METHYLAZOBENZENE; CARCINOGEN; GLUCOSE 6 PHOSPHATASE; GLYCOGEN; HEPATITIS B SURFACE ANTIGEN; N (2 FLUORENYL) ACETAMIDE; NITROSOMORPHOLINE; UNCLASSIFIED DRUG;

ARTICLE; CARBOHYDRATE METABOLISM; CHROMOSOME MOSAICISM; GLUCONEOGENESIS; GLYCOGEN STORAGE DISEASE; GLYCOLYSIS; HUMAN; HYALINE DEGENERATION; HYPERTROPHY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PENTOSE PHOSPHATE CYCLE; PHENOTYPE; RISK; SMOOTH ENDOPLASMIC RETICULUM; STEATOSIS; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84877771660     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v18.i46.6701     Document Type: Article

References (99)

1. Callea F, Giovannoni I, Stefanelli M, Villanacci V, Lorini G, Francalanci P. Glycogenotic hepatocellular carcinoma with glycogen-ground-glass hepatocytes: histological, histochemical and microbiochemical characterization of the novel variant. Histopathology 2012; 60: 1010-1012
2. Bannasch P, Hacker HJ, Klimek F, Mayer D. Hepatocellular glycogenosis and related pattern of enzymatic changes during hepatocarcinogenesis. Adv Enzyme Regul 1984; 22: 97-121
3. Bannasch P, Mueller HA. [Light microscopic studies on the effects of n-nitrosomorpholine on the liver of rats and mice]. Arzneimittelforschung 1964; 14: 805-814
4. Bannasch P. The cytoplasm of hepatocytes during carcinogenesis. Electron and light microscopical investigations of the nitrosomorpholine-intoxicated rat liver. In: Rentchnick P, editor. Recent Results in Cancer Research. Vol. 19. Heidelberg: Springer, 1968: 1-100
5. Klinge O, Bannasch P. [The increase of smooth endoplasmatic reticulum in hepatocytes of human liver punctates]. Verh Dtsch Ges Pathol 1968; 52: 568-573
6. Bannasch P, Klinge O. [Hepatocellular glycogenosis and hepatoma development in man]. Virchows Arch A Pathol Pathol Anat 1971; 352: 157-164
7. Bannasch P. Pathogenesis of hepatocellular carcinoma: sequential cellular, molecular, and metabolic changes. Prog Liver Dis 1996; 14: 161-197
8. Bannasch P, Schröder CH. Tumors and tumor-like lesions of the liver and biliary tract: pathogenesis of primary liver tumors. In: MacSween RNM, Burt AD, Portman BC, Ishak KG, Scheuer PJ, Anthony PP, editors. Pathology of the Liver. 4th ed. London: Churchill Livingstone, 2002: 777-825
9. Bannasch P, Mayer D, Hacker HJ. Hepatocellular glycogenosis and hepatocarcinogenesis. Biochim Biophys Acta 1980; 605: 217-245
10. Porter KR, Bruni C. An electron microscope study of the early effects of 3'-Me-DAB on rat liver cells. Cancer Res 1959; 19: 997-1009
11. Bruni C. Hyaline degeneration of rat liver cells studied with the electron microscope. Lab Invest 1960; 9: 209-215
12. Steiner JW, Miyai K, Phillips MJ. Electron microscopy of membrane-particle arrays in liver cells of ethionine-intoxicated rats. Am J Pathol 1964; 44: 169-214
13. Carter JH, Carter HW, Deddens JA, Hurst BM, George MH, DeAngelo AB. A 2-year dose-response study of lesion sequences during hepatocellular carcinogenesis in the male B6C3F(1) mouse given the drinking water chemical dichloro-acetic acid. Environ Health Perspect 2003; 111: 53-64
14. Bannasch P, Khoshkhou NI, Hacker HJ, Radaeva S, Mrozek M, Zillmann U, Kopp-Schneider A, Haberkorn U, Elgas M, Tolle T. Synergistic hepatocarcinogenic effect of hepadnaviral infection and dietary aflatoxin B1 in woodchucks. Cancer Res 1995; 55: 3318-3330
15. Radaeva S, Li Y, Hacker HJ, Burger V, Kopp-Schneider A, Bannasch P. Hepadnaviral hepatocarcinogenesis: in situ visualization of viral antigens, cytoplasmic compartmentation, enzymic patterns, and cellular proliferation in preneoplastic hepatocellular lineages in woodchucks. J Hepatol 2000; 33: 580-600
16. Xu C, Yamamoto T, Zhou T, Aldrich CE, Frank K, Cullen JM, Jilbert AR, Mason WS. The liver of woodchucks chronically infected with the woodchuck hepatitis virus contains foci of virus core antigen-negative hepatocytes with both altered and normal morphology. Virology 2007; 359: 283-294
17. Toshkov I, Chisari FV, Bannasch P. Hepatic preneoplasia in hepatitis B virus transgenic mice. Hepatology 1994; 20: 1162-1172
18. Dombrowski F, Bannasch P, Pfeifer U. Hepatocellular neoplasms induced by low-number pancreatic islet transplants in streptozotocin diabetic rats. Am J Pathol 1997; 150: 1071-1087
19. Dombrowski F, Mathieu C, Evert M. Hepatocellular neo-plasms induced by low-number pancreatic islet transplants in autoimmune diabetic BB/Pfd rats. Cancer Res 2006; 66: 1833-1843
20. Bannasch P. Cytology and cytogenesis of neoplastic (hyper-plastic) hepatic nodules. Cancer Res 1976; 36: 2555-2562
21. Bannasch P, Hesse J, Angerer H. [Hepatocellular glycogenosis and the genesis of so-called hyperplastic liver nodules in thioacetamide intoxicated rats (author's transl)]. Virchows Arch B Cell Pathol 1974; 17: 29-50
22. Farber E. Hyperplastic liver nodules. In: Busch H, editor. Methods Cancer Research. Vol. 7. New York: Academic Press, 1973: 345-379
23. Merkow LP, Epstein SM, Slifkin M, Farber E, Pardo M. Ultrastructural alterations within hyperplastic liver nodules induced by ethionine. Cancer Res 1971; 31: 174-178
24. Bannasch P, Klimek F, Mayer D. Early bioenergetic changes in hepatocarcinogenesis: preneoplastic phenotypes mimic responses to insulin and thyroid hormone. J Bioenerg Biomembr 1997; 29: 303-313
25. Gössner W, Friedrich-Freska H. [Histochemical studies on glucose-6-phosphatase in the rat liver during cancerization by nitrosamine]. Z Naturforsch B 1964; 19: 862-863
26. Epstein S, Ito N, Merkow L, Farber E. Cellular analysis of liver carcinogenesis: the induction of large hyperplastic nodules in the liver with 2-fluorenylacetamide or ethionine and some aspects of their morphology and glycogen metabolism. Cancer Res 1967; 27: 1702-1711
27. Friedrich-Freksa H, Gössner W, Börner P. [Histochemical investigations of carcinogenesis in rat liver after continuous application of diethylnitrosamine]. Z Krebsforsch 1969; 72: 226-239
28. Bianchi L. Glycogen storage disease I and hepatocellular tumors. Eur J Pediatr 1993; 152 Suppl 1: S63-S70
29. Mutel E, Abdul-Wahed A, Ramamonjisoa N, Stefanutti A, Houberdon I, Cavassila S, Pilleul F, Beuf O, Gautier-Stein A, Penhoat A, Mithieux G, Rajas F. Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas. J Hepatol 2011; 54: 529-537
30. Moore MA, Tatematsu M. Are the Phenotypes of Preneoplastic Lesions of Significance for Cancer Prevention? 1. Liver. Asian Pac J Cancer Prev 2001; 2: 27-42
31. Hacker HJ, Moore MA, Mayer D, Bannasch P. Correlative histochemistry of some enzymes of carbohydrate metabolism in preneoplastic and neoplastic lesions in the rat liver. Carcinogenesis 1982; 3: 1265-1272
32. Evert M, Schneider-Stock R, Dombrowski F. Overexpression of fatty acid synthase in chemically and hormonally induced hepatocarcinogenesis of the rat. Lab Invest 2005; 85: 99-108
33. Williams GM, Klaiber M, Parker SE, Farber E. Nature of early appearing, carcinogen-induced liver lesions to iron accumulation. J Natl Cancer Inst 1976; 57: 157-165
34. Klimek F, Bannasch P. Isoenzyme shift from glucokinase to hexokinase is not an early but a late event in hepatocarcinogenesis. Carcinogenesis 1993; 14: 1857-1861
35. Nehrbass D, Klimek F, Bannasch P. Overexpression of insulin receptor substrate-1 emerges early in hepatocarcinogenesis and elicits preneoplastic hepatic glycogenosis. Am J Pathol 1998; 152: 341-345
36. Aleem E, Nehrbass D, Klimek F, Mayer D, Bannasch P. Upregulation of the insulin receptor and type I insulin-like growth factor receptor are early events in hepatocarcinogenesis. Toxicol Pathol 2011; 39: 524-543
37. Scharf JG, Ramadori G, Dombrowski F. Analysis of the IGF axis in preneoplastic hepatic foci and hepatocellular neoplasms developing after low-number pancreatic islet transplantation into the livers of streptozotocin diabetic rats. Lab Invest 2000; 80: 1399-1411
38. Evert M, Sun J, Pichler S, Slavova N, Schneider-Stock R, Dombrowski F. Insulin receptor, insulin receptor substrate-1, Raf-1, and Mek-1 during hormonal hepatocarcinogenesis by intrahepatic pancreatic islet transplantation in diabetic rats. Cancer Res 2004; 64: 8093-8100
39. Evert M, Calvisi DF, Evert K, De Murtas V, Gasparetti G, Mattu S, Destefanis G, Ladu S, Zimmermann A, Delogu S, Thiel S, Thiele A, Ribback S, Dombrowski F. V-AKT murine thymoma viral oncogene homolog/mammalian target of rapamycin activation induces a module of metabolic changes contributing to growth in insulin-induced hepatocarcinogenesis. Hepatology 2012; 55: 1473-1484
40. Histologic typing of liver tumors of the rat. Institute of Laboratory Animal Resources, National Research Council, National Academy of Sciences, Washington, D.C. J Natl Cancer Inst 1980; 64: 177-206
41. Bannasch P. Preneoplastic lesions as end points in carcinogenicity testing. I. Hepatic preneoplasia. Carcinogenesis 1986; 7: 689-695
42. Bannasch P, Haertel T, Su Q. Significance of hepatic preneoplasia in risk identification and early detection of neoplasia. Toxicol Pathol 2003; 31: 134-139
43. Moore MA, Mayer D, Bannasch P. The dose dependence and sequential appearance of putative preneoplastic populations induced in the rat liver by stop experiments with N-nitrosomorpholine. Carcinogenesis 1982; 3: 1429-1436
44. Enzmann H, Bannasch P. Potential significance of phenotypic heterogeneity of focal lesions at different stages in hepatocarcinogenesis. Carcinogenesis 1987; 8: 1607-1612
45. Weber E, Bannasch P. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by continuous oral exposure to N-nitrosomorpholine. Carcinogenesis 1994; 15: 1235-1242
46. Kim CM, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991; 351: 317-320
47. Thierbach R, Florian S, Wolfrum K, Voigt A, Drewes G, Blume U, Bannasch P, Ristow M, Steinberg P. Specific alterations of carbohydrate metabolism are associated with hepatocarcinogenesis in mitochondrially impaired mice. Hum Mol Genet 2012; 21: 656-663
48. Zerban H, Radig S, Kopp-Schneider A, Bannasch P. Cell proliferation and cell death (apoptosis) in hepatic preneoplasia and neoplasia are closely related to phenotypic cellular diversity and instability. Carcinogenesis 1994; 15: 2467-2473
49. Kopp-Schneider A, Portier C, Bannasch P. A model for hepatocarcinogenesis treating phenotypical changes in focal hepatocellular lesions as epigenetic events. Math Biosci 1998; 148: 181-204
50. Ghoshal AK, Farber E. The induction of liver cancer by dietary deficiency of choline and methionine without added carcinogens. Carcinogenesis 1984; 5: 1367-1370
51. Pogribny IP, Ross SA, Wise C, Pogribna M, Jones EA, Tryndyak VP, James SJ, Dragan YP, Poirier LA. Irreversible global DNA hypomethylation as a key step in hepatocarcinogenesis induced by dietary methyl deficiency. Mutat Res 2006; 593: 80-87
52. Pogribny IP, Shpyleva SI, Muskhelishvili L, Bagnyukova TV, James SJ, Beland FA. Role of DNA damage and alterations in cytosine DNA methylation in rat liver carcinogenesis induced by a methyl-deficient diet. Mutat Res 2009; 669: 56-62
53. Altmann HW. Hepatic neoformations. Pathol Res Pract 1994; 190: 513-577
54. Buchanan TF, Huvos AG. Clear-cell carcinoma of the liver. A clinicopathologic study of 13 patients. Am J Clin Pathol 1974; 61: 529-539
55. Garancis JC, Tang T, Panares R, Jurevics I. Hepatic adenoma. Biochemical and electron microscopic study. Cancer 1969; 24: 560-568
56. Hamperl H. "Adrenal rest-tumors" (hypernephromas) of the liver. Z Krebsforsch 1970; 74: 310-317
57. Wu PC, Lai CL, Lam KC, Lok AS, Lin HJ. Clear cell carcinoma of liver. An ultrastructural study. Cancer 1983; 52: 504-507
58. Sasaki K, Okuda S, Takahashi M, Sasaki M. Hepatic clear cell carcinoma associated with hypoglycemia and hypercholesterolemia. Cancer 1981; 47: 820-822
59. Balázs M. [Light and electron microscopie examination of a case of primary liver carcinoma in an infant (author's transl)]. Zentralbl Allg Pathol 1976; 120: 3-13
60. Cain H, Kraus B. [Developmental anomalies of the liver and carcinoma of the liver in infants and children (author's transl)]. Dtsch Med Wochenschr 1977; 102: 505-509
61. Fischer G, Hartmann H, Droese M, Schauer A, Bock KW. Histochemical and immunohistochemical detection of putative preneoplastic liver foci in women after long-term use of oral contraceptives. Virchows Arch B Cell Pathol Incl Mol Pathol 1986; 50: 321-337
62. Karhunen PJ, Penttilä A. Preneoplastic lesions of human liver. Hepatogastroenterology 1987; 34: 10-15
63. Cattan S, Wendum D, Chazouilleres O, Schmitz J, Gendre JP. Hepatocellular carcinoma and focal hepatic glycogenosis after prolonged azathioprine therapy. Hum Pathol 2000; 31: 874-876
64. Klein WM, Molmenti EP, Colombani PM, Grover DS, Schwarz KB, Boitnott J, Torbenson MS. Primary liver carcinoma arising in people younger than 30 years. Am J Clin Pathol 2005; 124: 512-518
65. Chen SC, Cummings OW, Hartley MP, Filomena CA, Cho WK. Hepatocellular carcinoma occurring in a patient with Crohn's disease treated with both azathioprine and infliximab. Dig Dis Sci 2006; 51: 952-955
66. Murakami A, Tanaka Y, Ueda M, Nagano Y, Kunisaki R, Morimoto M, Enaka M, Tanabe M, Kawachi K, Sasaki T, Nozawa A. Hepatocellular carcinoma occurring in a young Crohn's disease patient. Pathol Int 2009; 59: 492-496
67. Ishida M, Naka S, Shiomi H, Tsujikawa T, Andoh A, Nakahara T, Saito Y, Kurumi Y, Takikita-Suzuki M, Kojima F, Hotta M, Tani T, Fujiyama Y, Okabe H. Hepatocellular carcinoma occurring in a Crohn's disease patient. World J Gastroenterol 2010; 16: 3215-3218
68. Su Q, Benner A, Hofmann WJ, Otto G, Pichlmayr R, Bannasch P. Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia. Virchows Arch 1997; 431: 391-406
69. Evert M, Dombrowski F. [Hepatocellular carcinoma in the non-cirrhotic liver]. Pathologe 2008; 29: 47-52
70. Hirota N, Hamazaki M, Williams GM. Resistance to iron accumulation and presence of hepatitis B surface antigen in preneoplastic and neoplastic lesions in human hemochromatotic livers. Hepatogastroenterology 1982; 29: 49-51
71. Mori H, Tanaka T, Sugie S, Takahashi M, Williams GM. DNA content of liver cell nuclei of N-2-fluorenylacetamide-induced altered foci and neoplasms in rats and human hyperplastic foci. J Natl Cancer Inst 1982; 69: 1277-1282
72. Deugnier YM, Charalambous P, Le Quilleuc D, Turlin B, Searle J, Brissot P, Powell LW, Halliday JW. Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: a study of 185 patients. Hepatology 1993; 18: 1363-1369
73. Sá Cunha A, Blanc JF, Trillaud H, De Ledinghen V, Balabaud C, Bioulac-Sage P. Hypervascular nodule in a fibrotic liver overloaded with iron: identification of a premalignant area with preserved liver architecture. Comp Hepatol 2005; 4: 5
74. Bannasch P, Jahn U, Hacker H, Su Q, Hoffmann W, Pichlmayr R, Otto G. Focal hepatic glycogenosis. Int J Oncol 1997; 10: 261-268
75. Su Q, Bannasch P. Relevance of hepatic preneoplasia for human hepatocarcinogenesis. Toxicol Pathol 2003; 31: 126-133
76. Terasaki S, Kaneko S, Kobayashi K, Nonomura A, Nakanuma Y. Histological features predicting malignant transformation of nonmalignant hepatocellular nodules: a prospective study. Gastroenterology 1998; 115: 1216-1222
77. Gong L, Li YH, Su Q, Chu X, Zhang W. Clonality of nodular lesions in liver cirrhosis and chromosomal abnormalities in monoclonal nodules of altered hepatocytes. Histopathology 2010; 56: 589-599
78. Cai YR, Gong L, Teng XY, Zhang HT, Wang CF, Wei GL, Guo L, Ding F, Liu ZH, Pan QJ, Su Q. Clonality and allele-type analyses of focal nodular hyperplasia compared with hepatocellular adenoma and carcinoma. World J Gastroenterol 2009; 15: 4695-4708
79. Laurent C, Quaglia A, Foroni L, Bioulac-Sage P, Balabaud C, Dhillon AP. Genomic alteration is not associated with fatty and clear cell change in hepatocellular carcinomas and its precursor nodular lesions in cirrhotic liver. Hepatol Res 2006; 36: 40-47
80. Pogribny IP, Rusyn I. Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma. Cancer Lett 2012 Feb 2 [Epub ahead of print]
81. Hadziyannis S, Gerber MA, Vissoulis C, Popper H. Cytoplasmic hepatitis B antigen in "ground-glass" hepatocytes of carriers. Arch Pathol 1973; 96: 327-330
82. Popper H. The ground glass hepatocyte as a diagnostic hint. Hum Pathol 1975; 6: 517-520
83. Su IJ, Wang HC, Wu HC, Huang WY. Ground glass hepatocytes contain pre-S mutants and represent preneoplastic lesions in chronic hepatitis B virus infection. J Gastroenterol Hepatol 2008; 23: 1169-1174
84. Wills EJ. Ground glasslike hepatocytes produced by glycogen-membrane complexes ("glycogen bodies"). Ultrastruct Pathol 1992; 16: 491-503
85. Su Q, Zerban H, Otto G, Bannasch P. Cytokeratin expression is reduced in glycogenotic clear hepatocytes but increased in ground-glass cells in chronic human and woodchuck hepadnaviral infection. Hepatology 1998; 28: 347-359
86. Wisell J, Boitnott J, Haas M, Anders RA, Hart J, Lewis JT, Abraham SC, Torbenson M. Glycogen pseudoground glass change in hepatocytes. Am J Surg Pathol 2006; 30: 1085-1090
87. Bejarano PA, Garcia MT, Rodriguez MM, Ruiz P, Tzakis G. Liver glycogen bodies: ground-glass hepatocytes in transplanted patients. Virchows Arch 2006; 449: 539-545
88. Mauriac P. Gros ventre, hepatomegalie, troubles de las croissance chez les enfants diabetiques traits depuis plusieurs annes par l'insuline. Gaz Hebd Sci Med Bordeaux 1930; 26: 402-404
89. Evans RW, Littler TR, Pemberton HS. Glycogen storage in the liver in diabetes mellitus. J Clin Pathol 1955; 8: 110-113
90. Chatila R, West AB. Hepatomegaly and abnormal liver tests due to glycogenosis in adults with diabetes. Medicine (Baltimore) 1996; 75: 327-333
91. Torbenson M, Chen YY, Brunt E, Cummings OW, Gottfried M, Jakate S, Liu YC, Yeh MM, Ferrell L. Glycogenic hepatopathy: an underrecognized hepatic complication of diabetes mellitus. Am J Surg Pathol 2006; 30: 508-513
92. Vaishnava H, Gulati PD, Damodaran VN. Observations on the structure and function of liver in Indian diabetics. Diabetologia 1970; 6: 21-26
93. Tsujimoto T, Takano M, Nishiofuku M, Yoshiji H, Matsumura Y, Kuriyama S, Uemura M, Okamoto S, Fukui H. Rapid onset of glycogen storage hepatomegaly in a type-2 diabetic patient after a massive dose of long-acting insulin and large doses of glucose. Intern Med 2006; 45: 469-473
94. Wolfsdorf JI, Weinstein DA. Glycogen storage diseases. Rev Endocr Metab Disord 2003; 4: 95-102
95. Mason HH, Andersen DH. Glycogen disease of the liver (von Gierke's disease) with hepatomata; case report with metabolic studies. Pediatrics 1955; 16: 785-800
96. Alshak NS, Cocjin J, Podesta L, van de Velde R, Makowka L, Rosenthal P, Geller SA. Hepatocellular adenoma in glycogen storage disease type IV. Arch Pathol Lab Med 1994; 118: 88-91
97. Labrune P, Trioche P, Duvaltier I, Chevalier P, Odièvre M. Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr 1997; 24: 276-279
98. Demo E, Frush D, Gottfried M, Koepke J, Boney A, Bali D, Chen YT, Kishnani PS. Glycogen storage disease type III-hepatocellular carcinoma a long-term complication? J Hepatol 2007; 46: 492-498
99. Manzia TM, Angelico R, Toti L, Cillis A, Ciano P, Orlando G, Anselmo A, Angelico M, Tisone G. Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: two case reports. Transplant Proc 2011; 43: 1181-1183